It’s interesting that the Department of Defense recently awarded a grant to Frequency Therapeutics. They appear to be excited at the potential.
A quote from the CEO of the company: “The DOD’s Hearing and Balance Research Award provides meaningful, peer-reviewed validation as we move toward Phase 2 clinical trials in hearing restoration later this year,” said David Lucchino, President, Co-founder and CEO of Frequency. “With this award, we have the potential to help thousands of men and women in uniform.”
Fingers crossed that these trials go well!